NO20030431L - Acetamidderivater og anvendelse derav som inhibitorer for koagulasjonsfaktorene Xa og VIIa - Google Patents

Acetamidderivater og anvendelse derav som inhibitorer for koagulasjonsfaktorene Xa og VIIa

Info

Publication number
NO20030431L
NO20030431L NO20030431A NO20030431A NO20030431L NO 20030431 L NO20030431 L NO 20030431L NO 20030431 A NO20030431 A NO 20030431A NO 20030431 A NO20030431 A NO 20030431A NO 20030431 L NO20030431 L NO 20030431L
Authority
NO
Norway
Prior art keywords
viia
inhibitors
coagulation factors
acetamide derivatives
tumor
Prior art date
Application number
NO20030431A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030431D0 (no
Inventor
Werner Mederski
Horst Juraszyk
Dieter Dorsch
Christos Tsaklakidis
Johannes Gleitz
Christopher Barnes
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20030431D0 publication Critical patent/NO20030431D0/no
Publication of NO20030431L publication Critical patent/NO20030431L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02Monothiocarbamic acids; Derivatives thereof
    • C07C333/08Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20030431A 2000-07-29 2003-01-28 Acetamidderivater og anvendelse derav som inhibitorer for koagulasjonsfaktorene Xa og VIIa NO20030431L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10037146A DE10037146A1 (de) 2000-07-29 2000-07-29 Acetamidderivate
PCT/EP2001/007594 WO2002010127A1 (de) 2000-07-29 2001-07-03 Acetamidderivate und ihre verwendung als inhibitoren des koagulationsfaktors xa und viia

Publications (2)

Publication Number Publication Date
NO20030431D0 NO20030431D0 (no) 2003-01-28
NO20030431L true NO20030431L (no) 2003-01-28

Family

ID=7650757

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030431A NO20030431L (no) 2000-07-29 2003-01-28 Acetamidderivater og anvendelse derav som inhibitorer for koagulasjonsfaktorene Xa og VIIa

Country Status (18)

Country Link
US (1) US20030187037A1 (ko)
EP (1) EP1309549A1 (ko)
JP (1) JP2004505106A (ko)
KR (1) KR20030029531A (ko)
CN (1) CN1444561A (ko)
AR (1) AR029999A1 (ko)
AU (1) AU2001281941A1 (ko)
BR (1) BR0112813A (ko)
CA (1) CA2417427A1 (ko)
CZ (1) CZ2003465A3 (ko)
DE (1) DE10037146A1 (ko)
HU (1) HUP0301502A2 (ko)
MX (1) MXPA03000780A (ko)
NO (1) NO20030431L (ko)
PL (1) PL358756A1 (ko)
SK (1) SK1972003A3 (ko)
WO (1) WO2002010127A1 (ko)
ZA (1) ZA200301633B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819548A1 (de) * 1998-04-30 1999-11-04 Merck Patent Gmbh Biphenylderivate
WO2000071508A2 (en) * 1999-05-24 2000-11-30 Cor Therapeutics, Inc. INHIBITORS OF FACTOR Xa
CA2382751A1 (en) * 1999-05-24 2000-11-30 Cor Therapeutics, Inc. Inhibitors of factor xa
AU2001243598A1 (en) * 2000-03-13 2001-09-24 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade

Also Published As

Publication number Publication date
AR029999A1 (es) 2003-07-23
JP2004505106A (ja) 2004-02-19
EP1309549A1 (de) 2003-05-14
NO20030431D0 (no) 2003-01-28
CA2417427A1 (en) 2003-01-27
CN1444561A (zh) 2003-09-24
US20030187037A1 (en) 2003-10-02
CZ2003465A3 (cs) 2003-05-14
HUP0301502A2 (hu) 2003-08-28
DE10037146A1 (de) 2002-02-07
SK1972003A3 (en) 2003-06-03
PL358756A1 (en) 2004-08-23
WO2002010127A1 (de) 2002-02-07
AU2001281941A1 (en) 2002-02-13
ZA200301633B (en) 2004-06-22
BR0112813A (pt) 2003-07-01
KR20030029531A (ko) 2003-04-14
MXPA03000780A (es) 2003-06-04

Similar Documents

Publication Publication Date Title
DE60127863D1 (de) Phenylderivate
MY133897A (en) N-(4-carb-amimidophenyl) glycineamide derivatives
TR200200649T2 (tr) Farmasötik özelliklere sahip olan yeni aminodikarboksilik asit türevleri
ATE405266T1 (de) Monozyklische oder bizyklische carbozyklen und heterozyklen als hemmer von factor xa
AR023777A1 (es) Nuevos compuestos
NO996316L (no) Faktor Xa-inhibitorer med en noeytral P1-spesifisitetsgruppe
EA200300017A1 (ru) Ингибиторы серинпротеазы
ATE411288T1 (de) Aryl-, aryloxy- und alkyloxysubstituierte 1h- indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
DE60122176D1 (de) Isoxazole und ihre verwendung als erk-inhibitoren
UY26926A1 (es) Derivados de la quinolina y quinazolina
BR0112292A (pt) Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto
ATE392421T1 (de) Von pyrazol abgeleitete kinaseinhibitoren und deren verwendung
ATE491701T1 (de) Von pyrazol abgeleitete kinaseinhibitoren und deren verwendung
MXPA05013536A (es) Derivados de etinilprolina.
WO2000071516A3 (en) INHIBITORS OF FACTOR Xa
ATE275544T1 (de) Serinprotease-inhibitoren
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
NO20052994L (no) Nye fosforamidderivater.
ATE325135T1 (de) 2-alkylierte cyclodextrinderivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung
BR0109512A (pt) Imidazopiridinas tricìclicas
NO20015892D0 (no) Inhibitorer av metallproteinaser
MXPA03010205A (es) Derivados de acido oxalico.
NO20030431L (no) Acetamidderivater og anvendelse derav som inhibitorer for koagulasjonsfaktorene Xa og VIIa
EA200301101A1 (ru) Производные пиперазина и их применение в качестве ингибиторов pde4
MY134079A (en) Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny]-valerian-acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application